The firms will combine Caris' multimodal genomic data with Ontada's community oncology-based real-world data to support cancer drug development.

GeneDx Corp's 2024 success story: profitability, 100x returns, NICU market expansion, pediatric neurology diagnostics, and ...

Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced a strategic and multi-faceted collaboration with Ontada®, a business ...